Staff Electrical Engineer
Illumina
Staff Electrical Engineer
Illumina
Develops sequencing platforms and consumables
We are a leader in the development of innovative DNA sequencing instruments that transform the landscape of genomics. Our flagship products, such as the NovaSeq X and 6K series, drive scientific discoveries across healthcare and biotechnology. Join us and bring your expertise to products that make a difference globally.
As a Staff Electrical Engineer in our Lifecycle Management team, you will be a technical leader responsible for overseeing the entire electrical-system lifecycle of our high-performance sequencing products — from New Product Introduction (NPI) through sustaining phases until end-of-life. You will lead and manage technical LCM projects end-to-end, guiding a sub-team of engineers while personally driving the most complex technical investigations.
This role demands a dynamic, fast-learning, and highly flexible engineer who can manage component End-of-Life (EOL), drive supplier and design changes, and lead product improvements — all while adhering to our Standard Operating Procedures (SOPs), Work Instructions (WIs), and software/PLM platforms. Critically, you must be comfortable owning the High-Performance Compute (HPC) / Compute Engine (CE) server domain, which increasingly defines instrument performance and cost on top of generic CPU/FPGA based electronics. You will have the opportunity to lead, mentor, and grow the team, and to progress toward broader electrical-systems engineering leadership.
Key Responsibilities:
LCM Operation — Technical Project Management
HPC / Compute Engine (Server) Domain
Compliance, Quality & Test
Leadership & Mentorship
Technical Requirements:
Qualifications:
Why Join Us?
Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.
Explore more opportunities at Illumina